Most people walk out of a FibroScan scan holding a printout with two numbers and no real explanation of what they represent. A FibroScan report gives you two distinct measurements — liver stiffness in kPa and a CAP score in dB/m. One measures scarring. The other measures fat. They answer different questions about the same organ, and reading one without understanding the other gives you half a picture.
Here’s how to read your FibroScan report properly — not just against a generic reference table, but with the clinical context that makes the numbers actually meaningful.
What Do the Two Numbers on a FibroScan Report Actually Mean?
Transient elastography — the technology behind the FibroScan device — captures two measurements in a single 10–15 minute session. They appear together on the printout, but they’re answering completely different clinical questions.
Liver stiffness (kPa):
This measures how stiff the liver tissue is. Stiffer liver equals more scar tissue. The machine sends a mild vibration into the liver and measures how fast a shear wave travels through it — stiffer tissue transmits it faster. The resulting kPa reading reflects the degree of liver fibrosis. Normal liver tissue is soft and pliable. Tissue progressively replaced by scar becomes rigid. The kPa number tells you where on that spectrum your liver currently sits.
CAP score (dB/m):
CAP stands for Controlled Attenuation Parameter. It measures how much the ultrasound signal is dampened as it passes through liver tissue — fat absorbs the signal more than healthy cells. The higher the CAP score, the more fat is accumulating in the liver cells. This is hepatic steatosis — what most people call fatty liver.
One scan. Two answers. One about structure (scarring), one about content (fat). They’re both necessary because the clinical picture differs significantly across combinations:
- High fat, no fibrosis → the most recoverable scenario, lifestyle intervention has full effect
- Low fat, high fibrosis → another cause driving the scarring (Hepatitis B or C, alcohol, autoimmune)
- High fat and high fibrosis together → active progression, needs specialist-directed management
- Both normal → reassuring baseline
Reading them separately misses the story. Reading them together tells it.
Fibrosis Staging From Your kPa Reading
The liver stiffness kPa value is mapped to a fibrosis staging system — F0 through F4 — that reflects how much healthy liver tissue has been replaced by permanent scar.
Standard reference ranges:
| kPa Range | Fibrosis Stage | What It Means |
| Below 6.0 kPa | F0–F1 | Normal / no significant fibrosis |
| 6.0–7.9 kPa | F1–F2 | Mild fibrosis |
| 8.0–9.9 kPa | F2–F3 | Moderate fibrosis |
| 10.0–12.4 kPa | F3 | Significant fibrosis |
| 12.5 kPa and above | F4 | Cirrhosis range |
What the table doesn’t capture — and what matters practically:
These cutoffs vary slightly by the underlying disease. The kPa threshold for cirrhosis in Hepatitis C liver fibrosis is different from NAFLD-related cirrhosis, and different again for alcoholic liver disease. A gastroenterologist applies disease-specific cutoffs during interpretation — the generic table is a starting point, not the final word.
Stage also determines what’s still possible. Liver fibrosis at F0–F1 is genuinely reversible — treat the underlying cause, correct the metabolism, and FibroScan values measurably improve at follow-up. F2–F3 is harder but still responsive to intervention. F4 represents irreversible structural change — the management goal at that stage shifts from recovery to preventing complications like variceal bleeding, ascites, and hepatocellular carcinoma.
Serial readings matter more than any single number. A kPa reading of 8.5 trending down from 10.2 over 12 months of intervention tells a very different story than 8.5 that’s been creeping up from 6.1. Same number. Opposite implications.
How to Read a FibroScan CAP Score
The CAP score maps to a four-grade steatosis classification that reflects what percentage of liver cells contain fat droplets.
| CAP Score (dB/m) | Grade | Fat Level |
| Below 238 | S0 | Minimal or no fat (normal) |
| 238–259 | S1 | Mild hepatic steatosis |
| 260–290 | S2 | Moderate steatosis |
| Above 290 | S3 | Severe steatosis |
Several things the report doesn’t explain that matter for interpretation:
The CAP score is more dynamic than the kPa
Liver fat responds faster to metabolic changes than scar tissue does. A patient who cleans up their diet aggressively for 8–12 weeks may see their CAP score drop by 20–40 points before any meaningful kPa change shows up. Fat moves faster than fibrosis, in both directions — which means it also goes up faster if habits deteriorate.
Active liver inflammation artificially elevates both scores
During a period of significantly elevated liver enzymes — from a hepatitis flare, recent heavy alcohol use, or acute illness — liver stiffness can read falsely high, unrelated to actual scarring. This is why timing matters and why a repeat scan in a more stable clinical state sometimes gives a cleaner picture.
Severe CAP with low kPa is not a contradiction
A CAP score of 305 with a kPa of 5.1 means significant fat accumulation with no meaningful fibrosis yet. The liver is very fatty but hasn’t started scarring in response. This is the most actionable scenario — the window for full reversal is completely open.
Low CAP with high kPa needs a cause investigation
A CAP score of 210 with a kPa of 11 suggests significant scarring without much current fat — potentially burnt-out NASH (where the fat resolves as fibrosis advances), or a non-metabolic cause like Hepatitis B or C. The absence of fat doesn’t explain the fibrosis; something else does.
What Does a CAP Score of 300 Mean on a FibroScan?
A CAP score of 300 dB/m sits firmly in S3 — severe hepatic steatosis. More than two-thirds of liver cells are estimated to contain fat at this level.
On its own, 300 doesn’t mean crisis. It means the fat burden is significant enough that NASH — the inflammatory, damaging stage of fatty liver — is a realistic risk if it isn’t already present. What determines the actual urgency is the liver stiffness number sitting next to it on the same report.
Two completely different clinical pictures with the same CAP score of 300:
CAP 300 + kPa 4.8:
Severe steatosis, no significant fibrosis. The liver is carrying a lot of fat but hasn’t started scarring in response to it. This is the most recoverable scenario despite the high fat number. With meaningful lifestyle intervention — 7–10% weight loss, dietary correction, improved glycaemic control — a repeat FibroScan report in 6 months will often show a CAP score well into the 250s or below.
CAP 300 + kPa 11.2:
Severe steatosis with significant fibrosis simultaneously. Both problems are active and advanced. Lifestyle intervention remains important but isn’t sufficient alone — this requires specialist-directed management, likely including medications, structured monitoring, and a formal plan for fibrosis progression tracking.
The CAP score alone tells you the fat content. The story it tells — how urgent, what to do, how recoverable — only emerges when you read it alongside the kPa reading. Dr. Vibhor Pareek at Gastro Plus interprets both measurements together with the patient’s full clinical history in every FibroScan consultation — because a number without context is just a number.
Factors That Can Affect the Accuracy of Your FibroScan Report
A FibroScan report is reliable in most situations — but it isn’t infallible. Several factors can push numbers artificially high or low. Knowing them explains why your gastroenterologist may recommend a repeat scan before making clinical decisions based on a single result.
Factors that falsely elevate liver stiffness (kPa):
- Eating within 2 hours of the scan — post-meal portal blood flow increases liver stiffness readings independently of fibrosis
- Active liver inflammation — elevated enzymes from any cause can raise kPa without true fibrosis worsening
- Right-sided heart failure — increased venous pressure backs into the liver and elevates stiffness artificially
- Recent significant alcohol intake or acute hepatitis flare
Factors affecting CAP score accuracy:
- Meals before the scan — food in the gut temporarily affects signal attenuation and inflates the CAP score
- Dehydration — modestly affects reading consistency
- Very high BMI — deep tissue attenuation can interact with liver signal attenuation, affecting reliability
Factors affecting overall scan validity:
- BMI above 35–40 — the standard M probe has depth limitations; an XL probe is needed and not all centres have it
- Narrow intercostal spaces — probe positioning becomes difficult
- IQR/IQR median ratio above 30% on your report — this figure appears on most FibroScan report printouts and indicates result variability; above 30% means the reading should be interpreted cautiously and a repeat considered
When Your FibroScan Report Needs Specialist Attention
Not every result needs the same urgency. Knowing which category yours falls into is the actual point of having the test.
See a specialist promptly:
- kPa above 12.5 — cirrhosis range; needs full liver assessment, complication screening (endoscopy for varices, imaging for ascites), and management planning — not just a follow-up appointment in 6 months
- kPa 8–12.5 with elevated liver enzymes — significant liver fibrosis with active inflammation; the underlying cause needs identifying and treating without delay
- CAP above 290 + kPa above 8 — severe hepatic steatosis with moderate-significant fibrosis; NASH with active progression risk; needs specialist-directed management
- Any elevated kPa in a known Hepatitis B or C patient — viral load, disease phase, and fibrosis stage need assessing together; antiviral treatment decisions depend on all three
Act with structured follow-up:
- kPa 6–8 with normal enzymes — mild liver fibrosis; identify the underlying cause, address it, repeat FibroScan in 12 months
- CAP 260–290 with kPa below 6 — moderate steatosis, no meaningful fibrosis; the recovery window is fully open; lifestyle intervention with 6-monthly monitoring
Routine monitoring:
- kPa below 6, CAP below 238 — essentially normal; if the original reason for scanning was a specific risk factor or concern, annual monitoring is appropriate
Conclusion
A FibroScan report hands you two numbers that tell a specific, actionable story about your liver — if you know how to read them together. The kPa reading tells you about scarring. The CAP score tells you about fat. Read in isolation, each number is incomplete. Read in combination, with the right clinical context, they tell you exactly where your liver stands and — more usefully — what direction it can move in.
The important thing to take from this: these are snapshots, not sentences. Liver fibrosis responds to treating the underlying cause. Hepatic steatosis reverses with sustained metabolic correction. The same FibroScan report values represent very different futures depending on whether they’re acted on or filed away.
Know the number. Understand what drives it. Then do something about it — before the follow-up scan tells a harder story.
A FibroScan Result Means More When Someone Actually Explains It to You
Too many patients receive their FibroScan report as a printout with no accompanying explanation — just a number and a reference range. At Gastro Plus, FibroScan results are reviewed in clinic alongside your blood work, history, and underlying diagnosis, so you leave with a clear understanding of what the numbers mean and a specific plan for what comes next.
Dr. Vibhor Pareek and the Gastro Plus team offer:
- FibroScan in Gurgaon — liver stiffness and CAP score assessment with same-session specialist interpretation
- Fatty liver grading and NAFLD staging — fibrosis staging for patients with ultrasound-confirmed hepatic steatosis
- Hepatitis B and C monitoring — FibroScan as part of structured viral hepatitis follow-up protocols
- Post-FibroScan management planning — personalised intervention depending on your specific kPa and CAP result combination
- Serial FibroScan monitoring — tracking liver stiffness and fat content changes over time as treatment progresses
👉 Book a Consultation at Gastro Plus
Frequently Asked Questions
Q1. Is a 75 kPa FibroScan reading curable?
A kPa reading of 75 is extremely high — well beyond the cirrhosis threshold of 12.5 kPa — and would indicate very advanced, severe liver fibrosis or cirrhosis. Established cirrhosis is not reversible in the structural sense. However, treating the underlying cause (antiviral therapy for Hepatitis B or C, alcohol abstinence, metabolic control) can halt further progression and significantly reduce complication risk. At this reading, specialist evaluation should happen immediately — not deferred.
Q2. How do I lower my CAP score on FibroScan?
The CAP score reflects current hepatic fat — and fat responds to metabolic correction faster than fibrosis does. What consistently lowers it:
- 7–10% sustained weight loss — the most evidence-backed single intervention
- Reducing refined carbohydrates and fructose — directly reduces the liver’s fat synthesis input
- 150+ minutes of weekly aerobic activity — lowers hepatic steatosis independently of weight loss
Repeat FibroScan report in 6 months after sustained changes typically shows measurable CAP score reduction.
Q3. What is a completely normal FibroScan result?
A clean FibroScan report has liver stiffness below 6 kPa (no significant liver fibrosis) and a CAP score below 238 dB/m (no meaningful fat accumulation). Both values together in this range means the liver has no detectable scarring and no significant hepatic steatosis at the time of the scan. Even a normal result warrants the underlying reason for scanning being addressed — risk factors don’t disappear with a clean number.
Q4. Can FibroScan results change over time?
Yes — and this is one of the most important things to understand about the test. Liver stiffness kPa improves measurably in patients who treat the underlying cause of fibrosis (antiviral eradication for Hepatitis C, metabolic correction for NAFLD, alcohol abstinence). CAP score changes even faster — 3–6 months of sustained lifestyle changes can produce a significant drop. Serial monitoring is more informative than a single snapshot precisely because the direction of change is the most actionable piece of information.
Q5. How often should I repeat a FibroScan?
Depends on where you are. General guidance:
- F0–F1 with stable underlying cause: every 1–2 years
- F2 or above, or active underlying disease: every 6–12 months
- After starting antiviral therapy (Hepatitis B or C): at 12 months post-treatment to confirm fibrosis response
- After significant lifestyle changes for NAFLD: at 6 months to objectively assess whether hepatic steatosis and liver stiffness have responded
Q6. Can FibroScan replace a liver biopsy?
For most clinical situations — yes, and increasingly so. Transient elastography has 85–90% accuracy for significant liver fibrosis staging, is non-invasive, repeatable, and carries no complication risk. Liver biopsy remains the gold standard for genuinely ambiguous cases — where clinical, blood, and FibroScan data don’t align, or where the cause of fibrosis itself is uncertain. For routine NAFLD staging, Hepatitis B and C monitoring, and cirrhosis screening, a FibroScan report is sufficient without biopsy in the majority of patients
